“竹芪口服液”对恶性肿瘤患者放疗后白细胞和免疫球蛋白的影响

Effects on White Blood Cell and Immunoglobulin of Zhuqi - oral on Patients with Malignancy Oncoma

目的 观察“竹芪口服液”对恶性肿瘤患者放疗后白细胞和免疫球蛋白的影响。方法 将68例肺癌、鼻咽癌、宫颈癌患者随机分为治疗组(n=33)与对照组(n=35)。治疗组在放疗时服竹芪口服液,对照组服用模拟制剂。两组均定期进行血常规和免疫指标的测定,同时,观察有效率及肿块完全消失率。结果 血细胞降低幅度治疗组比对照组小而且回升速率快,有显著性差异(P<O.05);IgM、有效率、肿块完全消失率等治疗组高于对照组,有显著性差异(P<0.05)。结论“竹芪口服液”能明显提高恶性肿瘤患者放疗后白细胞和免疫球蛋白减少,延缓肿瘤的发展。提示“竹芪口服液”可作为抗肿瘤辅助药物。

Objective To observe the effect of Zhuqi-oral on White Blood Cell (WBC) and Im- munoglobulin(Ig) on patients with Malignancy Oncoma (MGO). Method 68 cases with MGO were randomly divided into two goups,namely the treating group(n=33) and control group (n =350: the treating group was treated with Zhuqi-oraj when radiotherapy while the control group with simmulated preparation. In the meantime, the effects rate and the vanish rate of tumor were obsaerved. Results It showed that the IgG、IgA、IgM、the WBC、the effects rate and the vanish rate of tumor on patients with the MGO of the treating group were remarkably high- er than those of the control group(p<0. 05). Conclusion The ZQO can improve the White Bloob Cell(WBC) and immunoglobulin of patients with Malignancy Oncoma(MGO) who have been treated by radiotherapy.